A high-risk OTC technology firm reporting zero revenue, heavy reliance on share-based compensation, and accumulating significant shareholder deficits without traditional income streams.
Bull case investors focus on the company's ability to monetize its accumulated R&D and intellectual property if a successful exit or partnership occurs. The zero tax liability and share-based compensation structure suggests management is trying to preserve cash for a turnaround event rather than immediate profitability.
Bearish factors include a deteriorating balance sheet with total liabilities of $8.8M exceeding shareholders' equity of $-8.7M, creating an insolvent capital structure. The consistent negative net income trend and lack of revenue generation make the stock unsuitable for value or growth investing strategies.
XERIANT, INC. (XERI) is a specialized technology entity operating with significant non-cash adjustments and substantial debt obligations under current OTC markets. The company reports zero revenue and massive accumulated deficits, relying heavily on equity financing rather than organic cash generation from operations. Key financial metrics include a $-1.6M net loss for the latest period and total liabilities of $8.8M against minimal current assets.
Management has failed to generate positive cash flow from operations or revenue, resulting in a net change in cash of -$608k over the reporting period. The company continues to burn cash with operating losses widening from $-7.1M in 2023 to $-1.6M in 2025 while relying on paid-in capital of $22.4M to stay solvent.
The technology sector in OTC markets often features early-stage companies with high burn rates and speculative valuation metrics that do not correlate with traditional P/E ratios. Companies like XERIANT typically operate until they can prove product-market fit or secure strategic funding before generating sustainable revenue streams.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $2.1M | $1.9M | $1.4M |
| Operating Income | $-2.1M | $-1.9M | $-1.4M |
| R&D | $0 | $196.4K | $69.3K |
| G&A | $302.7K | $282.2K | $309.1K |
| Stock-Based Comp | $702.1K | $0 | $442.6K |
| D&A | $1.5K | $1.5K | $1.6K |
| Other OpEx | $1.7M | $1.4M | $987.1K |
| Non-Operating Income | $0 | $0 | $-281.4K |
| Interest Expense | $10.6K | $1.2M | $225.6K |
| Pre-Tax Income | $-2.1M | $-1.9M | $-1.6M |
| Income Tax | $5.0M | $1.2M | $0 |
| Continuing Ops | $-7.1M | $-3.1M | $-1.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-7.1M | $-3.1M | $-1.6M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-7.1M | $-3.1M | $-1.6M |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Current Assets | $66.2K | $664.2K | $56.7K |
| Long-Term Assets | $101.0K | $48.8K | $11.5K |
| PP&E (Net) | $5.5K | $4.0K | $4.2K |
| Operating Leases | $82.9K | $32.3K | $7.4K |
| Other LT Assets | $12.5K | $12.5K | $0 |
| Total Assets | $167.1K | $713.0K | $68.2K |
| Current Liabilities | $6.8M | $9.3M | $8.8M |
| Current Leases | $56.0K | $36.2K | $4.3K |
| Other Current Liab | $6.7M | $9.3M | $8.8M |
| Long-Term Liabilities | $36.2K | $0 | $3.1K |
| LT Operating Leases | $36.2K | $0 | $3.1K |
| Other LT Liab | $0 | $0 | $0 |
| Total Liabilities | $6.8M | $9.3M | $8.8M |
| Shareholders' Equity | $-6.6M | $-8.6M | $-8.7M |
| Paid-In Capital | $3.9K | $20.9M | $22.4M |
| Retained Earnings | $-23.6M | $-26.7M | $-28.3M |
| Total L&E | $167.1K | $713.0K | $68.2K |
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Income (CFO) | $-7.1M | $-3.1M | $-1.6M |
| Non-Cash Adjustments | $5.8M | $443.6K | $444.0K |
| Working Capital Changes | $140.0K | $1.2M | $-85.6K |
| Cash from Operations | $-1.2M | $-1.4M | $-1.3M |
| Capital Expenditures | $2.6K | $0 | $1.8K |
| Cash from Investing | $-200.1K | $-8.2K | $-1.8K |
| Cash from Financing | $370.0K | $2.0M | $682.0K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-1.0M | $591.5K | $-608.3K |
| Beginning Cash | $1.1M | $61.6K | $653.1K |
| Ending Cash | $61.6K | $653.1K | $44.9K |
The financial structure indicates a single-segment entity where reported revenue is zero, with all activity driven by non-cash adjustments, share-based compensation of $442k, and financing cash flows rather than operational sales.
1) Severe liquidity crisis with current liabilities of $8.8M against only $56k in current assets and negative cash flow from operations of $1.3M. 2) Massive accumulated deficit of $-28.3M indicating long-term insolvency risk without external capital injection. 3) High interest expense of $225k on negligible operating profit creates a perpetual solvency threat.
Primary advantage includes a fully capitalized R&D model utilizing $69k in research expenses offset by $442k in share-based compensation to preserve cash. The company maintains a clean operating expense structure with zero cost of revenue and income tax expense, suggesting a service-based or asset-light operational model despite high liabilities.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.